Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13616501 | 0.88 | GAA (0.33) | ALDH1A1 | |
| SCHEMBL13616507 | 0.85 | — | — | |
| SCHEMBL17118242 | 0.82 | CYP3A4 (0.38) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL13616495 | 0.79 | DGKA (0.43) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL11816289 | 0.78 | ALDH1A1 (0.40) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL13258499 | 0.78 | ALDH1A1 (0.42) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL13616503 | 0.76 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL30978479 | 0.76 | DGKA (0.53) | ALDH1A1MAPK1 | |
| SCHEMBL30978486 | 0.76 | DGKA (0.53) | ALDH1A1MAPK1 | |
| SCHEMBL30978482 | 0.76 | DGKA (0.53) | ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090286878-A1 | POLYOL DERIVED ANTI-MICROBIAL AGENTS AND COMPOSITIONS | CIBA CORP. | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286878-A1 | POLYOL DERIVED ANTI-MICROBIAL AGENTS AND COMPOSITIONS | CUTA, PHOSPHO1, DPM1 | ALDH1A1 4256/4885TP53 1990/4885CYP3A4 2994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.